Updated in 6/2/2018 1:58:17 AM |
Viewed: 232 times |
(Journal Article) |
International Journal of Cancer Tom 120 strony 2007: 1795-1802
The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy.
JA Karam
,
J Fan
,
J Stanfield
,
E Richer
,
EA Benaim
,
E Frenkel
,
P Antich
,
AI Sagalowsky
,
RP Mason
,
J Hsieh
Notes
[Original String]:
46. Karam J. A., Fan J., Stanfield J., Richer E., Benaim E. A., Frenkel E., Antich P., Sagalowsky A. I., Mason R. P., Hsieh J. The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy. International Journal of Cancer. 2007, Tom 120, strony 1795-1802.